{"id":"vaginal-cream-with-applicator","safety":{"commonSideEffects":[{"rate":null,"effect":"Local irritation or burning"},{"rate":null,"effect":"Allergic reaction"},{"rate":null,"effect":"Vaginal discharge changes"}]},"_chembl":{"chemblId":"CHEMBL2108947","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Vaginal creams are topical formulations designed for intravaginal application via an applicator, allowing direct delivery of active pharmaceutical ingredients to vaginal tissues. The specific mechanism depends on the active ingredient(s) contained within the cream, which is not specified in the available information. Common vaginal cream actives work through antimicrobial, antifungal, hormonal, or anti-inflammatory mechanisms.","oneSentence":"A vaginal cream formulation that delivers therapeutic agents topically to treat local vaginal conditions.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:39:18.855Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Vaginal conditions (specific indication not specified)"}]},"trialDetails":[{"nctId":"NCT07474194","phase":"PHASE4","title":"Preoperative Clindamycin Vaginal Cream Versus Vaginal Cleansing With Povidone-iodine on Postoperative Infections After Cesarean Section","status":"RECRUITING","sponsor":"Beni-Suef University","startDate":"2025-09-20","conditions":"Infection Control / Methods, Surgical Site Infection (SSI)","enrollment":150},{"nctId":"NCT05672901","phase":"NA","title":"Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause","status":"RECRUITING","sponsor":"Stratpharma AG","startDate":"2023-04-04","conditions":"Genitourinary Syndrome of Menopause","enrollment":100},{"nctId":"NCT07246616","phase":"NA","title":"Efficacy and Safety of CO₂ Laser Therapy Combined With Collagen Cream in Managing Vulvo-Vaginal Atrophy: A Randomized, Controlled Study on Symptom Relief and Microbiome Modulation","status":"COMPLETED","sponsor":"Institute for Social Security, Republic of San Marino","startDate":"2024-06-01","conditions":"Vulva; Atrophy","enrollment":60},{"nctId":"NCT06873971","phase":"NA","title":"Er:YAG Laser Combined With Vaginal Estriol for Genitourinary Syndrome of Menopause","status":"RECRUITING","sponsor":"University of Nove de Julho","startDate":"2025-12-10","conditions":"Genitourinary Syndrome of Menopause","enrollment":60},{"nctId":"NCT04807894","phase":"PHASE4","title":"Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo","status":"RECRUITING","sponsor":"Maimonides Medical Center","startDate":"2020-11-01","conditions":"Recurrent Urinary Tract Infection, Vaginal Atrophy, Postmenopausal Disorder","enrollment":100},{"nctId":"NCT06192368","phase":"NA","title":"Virtual Reality Program to Reduce Stress in Neonatal Nurses","status":"COMPLETED","sponsor":"St. Justine's Hospital","startDate":"2024-06-19","conditions":"Virtual Reality, Stress, Stress, Work Place","enrollment":18},{"nctId":"NCT06391372","phase":"PHASE3","title":"Effect of Local Estriol Treatment Before Vaginal Repair Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hatice Tukenmez Kurnaz","startDate":"2024-04-01","conditions":"Pelvic Organ Prolapse, Pelvic Floor Disorders, Menopause","enrollment":36},{"nctId":"NCT06633705","phase":"PHASE4","title":"Changes in Neighbouring Microbiota in Genitourinary Syndrome","status":"COMPLETED","sponsor":"Koc University Hospital","startDate":"2023-11-10","conditions":"Genitourinary Syndrome of Menopause","enrollment":31},{"nctId":"NCT06425978","phase":"PHASE4","title":"Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2024-05-30","conditions":"Genitourinary Syndrome of Menopause","enrollment":192},{"nctId":"NCT06031493","phase":"PHASE4","title":"A Multimodal Intervention Program to Improve Sexual Health and Self-perceived Quality of Life in Patients Treated for Cervical Cancer (PROVIDENCE)","status":"UNKNOWN","sponsor":"Hospital Clinic of Barcelona","startDate":"2025-01","conditions":"Cervical Cancer, Sexual Dysfunction, Quality of Life","enrollment":122},{"nctId":"NCT06176820","phase":"PHASE2, PHASE3","title":"Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause","status":"UNKNOWN","sponsor":"Sarawak General Hospital","startDate":"2024-01-01","conditions":"Menopause Related Conditions, Atrophic Vaginitis, Genitourinary Syndrome of Menopause","enrollment":52},{"nctId":"NCT04487392","phase":"PHASE2","title":"Photobiomodulation Effect on Vulvovaginal Atrophy in Postmenopausal Women.","status":"WITHDRAWN","sponsor":"University of Nove de Julho","startDate":"2020-12-15","conditions":"Vulvovaginal Atrophy","enrollment":""},{"nctId":"NCT01448616","phase":"PHASE4","title":"Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding","status":"COMPLETED","sponsor":"University of Washington","startDate":"2012-02","conditions":"Herpes Simplex Type II","enrollment":73},{"nctId":"NCT01406197","phase":"NA","title":"Uterine Electrical Activity Before and After Progesterone Treatment for Preterm Labor","status":"WITHDRAWN","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2011-07","conditions":"Preterm Labor","enrollment":""},{"nctId":"NCT04606550","phase":"NA","title":"MonaLisa Laser Intervention for Post-Menopausal Breast Cancer Patients: A SHE CAN Study","status":"WITHDRAWN","sponsor":"Mount Sinai Hospital, Canada","startDate":"2021-09-01","conditions":"Breast Cancer Female, Genitourinary Syndrome of Menopause","enrollment":""},{"nctId":"NCT03774407","phase":"PHASE2, PHASE3","title":"Vaginal Estriol in Multiple Sclerosis","status":"COMPLETED","sponsor":"Texas Tech University Health Sciences Center","startDate":"2019-06-20","conditions":"Multiple Sclerosis, Neurogenic Bladder","enrollment":21},{"nctId":"NCT01959464","phase":"PHASE4","title":"Sexual Absorption of Vaginal Progesterone","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2008-11","conditions":"Infertility, Pregnancy","enrollment":20},{"nctId":"NCT03857893","phase":"NA","title":"New Non-Hormonal Treatment by Radiofrequency for Vulvo-Vaginal Atrophy","status":"TERMINATED","sponsor":"Serge Rozenberg","startDate":"2019-03-01","conditions":"Vulvo-vaginal Atrophy, Genitourinary Syndrome of Menopause","enrollment":53},{"nctId":"NCT04813822","phase":"PHASE2","title":"Study Evaluating the Efficacy and Safety of Miconazole Nitrate + Domiphen Bromide Vaginal Cream in the Treatment of Subjects With Acute Vulvovaginal Candidiasis","status":"UNKNOWN","sponsor":"Aesculape CRO Belgium BV","startDate":"2021-09-13","conditions":"Acute Vulvovaginal Candidiasis","enrollment":90},{"nctId":"NCT02835846","phase":"PHASE4","title":"Investigation of the Effect of the Female Urinary Microbiome on Incontinence","status":"COMPLETED","sponsor":"Loyola University","startDate":"2016-09","conditions":"Overactive Bladder, Incontinence, Nocturia","enrollment":35},{"nctId":"NCT02524769","phase":"NA","title":"The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides","status":"COMPLETED","sponsor":"Loyola University","startDate":"2015-12","conditions":"Overactive Bladder","enrollment":27},{"nctId":"NCT04232813","phase":"PHASE3","title":"Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream","status":"COMPLETED","sponsor":"Instituto Palacios","startDate":"2020-01-09","conditions":"Vulvovaginal Atrophy","enrollment":120},{"nctId":"NCT03385551","phase":"","title":"Study to Evaluate Estradiol Vaginal Tablets vs Promestriene Vaginal Cream","status":"COMPLETED","sponsor":"Instituto Palacios","startDate":"2019-12-09","conditions":"Vulvovaginal Atrophy","enrollment":120},{"nctId":"NCT04717245","phase":"NA","title":"Comparative Study: Vaginal Promestriene Use, Fractional CO2 LASER and Radiofrequency in the Vaginal Atrophy Treatment","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2018-10-25","conditions":"Vaginal Atrophy","enrollment":75},{"nctId":"NCT03823560","phase":"NA","title":"Performance and Safety of Class IIb MD Celegyn® in VVA","status":"UNKNOWN","sponsor":"Nathura S.p.A","startDate":"2019-09-24","conditions":"Vulvovaginal Atrophy","enrollment":96},{"nctId":"NCT03779633","phase":"PHASE4","title":"Preoperative Oestrogen in Postmenopausal Women With Pelvic Organ Prolapse","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2017-02-02","conditions":"Pelvic Organ Prolapse","enrollment":120},{"nctId":"NCT04393194","phase":"PHASE4","title":"The Effect of Intra-vaginal Conjugated Estrogen Cream on Ring Pessary Use for Pelvic Organ Prolapse","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2020-05-24","conditions":"Pelvic Floor Prolapse","enrollment":420},{"nctId":"NCT02710981","phase":"NA","title":"Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate in Infertile Women With Thin Endometrium","status":"COMPLETED","sponsor":"Assiut University","startDate":"2015-06","conditions":"Anovulation","enrollment":42},{"nctId":"NCT03281655","phase":"PHASE2","title":"Visnadine, Prenylflavonoids and Bovine Colostrum to Treat Vulvovaginal Atrophy in Postmenopausal Women","status":"COMPLETED","sponsor":"University of Messina","startDate":"2016-12","conditions":"Vulvovaginal Atrophy, Menopause","enrollment":54},{"nctId":"NCT00465894","phase":"NA","title":"Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2007-04","conditions":"Overactive Bladder","enrollment":58},{"nctId":"NCT02329171","phase":"PHASE3","title":"Imiquimod Treatment of CIN Lesions","status":"TERMINATED","sponsor":"Maastricht University Medical Center","startDate":"2014-12","conditions":"Cervical Intraepithelial Neoplasia","enrollment":9},{"nctId":"NCT03440359","phase":"PHASE2, PHASE3","title":"Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole","status":"COMPLETED","sponsor":"Eastern Virginia Medical School","startDate":"2012-07-06","conditions":"Polycystic Ovary Syndrome","enrollment":52},{"nctId":"NCT02269826","phase":"NA","title":"Efficacy and Safety of Non-hormonal Vaginal Preparations in Treating Vaginal Dryness","status":"COMPLETED","sponsor":"Dr. August Wolff GmbH & Co. KG Arzneimittel","startDate":"2008-02","conditions":"Vaginal Dryness","enrollment":117},{"nctId":"NCT02994342","phase":"NA","title":"Efficacy and Tolerability Study of ZP-025 Vaginal Gel for the Treatment of Vaginal Dryness","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2012-10","conditions":"Vaginal Dryness","enrollment":121},{"nctId":"NCT02380742","phase":"PHASE2","title":"Topical Anesthetic Use In Pessary Management","status":"COMPLETED","sponsor":"Loyola University","startDate":"2015-07","conditions":"Pain","enrollment":54},{"nctId":"NCT02419729","phase":"PHASE3","title":"Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy","status":"COMPLETED","sponsor":"Faculdade de Medicina do ABC","startDate":"2015-03","conditions":"Vulvovaginal Atrophy","enrollment":45},{"nctId":"NCT02640183","phase":"PHASE2","title":"EMLA Cream in Hysteroscopy Practice","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2015-09","conditions":"Anesthetics, Local","enrollment":184},{"nctId":"NCT01293643","phase":"PHASE3","title":"A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-05","conditions":"Vaginosis, Bacterial, Candidiasis, Vulvovaginal","enrollment":99},{"nctId":"NCT00803335","phase":"PHASE3","title":"The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse","status":"COMPLETED","sponsor":"TriHealth Inc.","startDate":"2008-12","conditions":"Pelvic Organ Prolapse, Vaginal Atrophy","enrollment":54},{"nctId":"NCT01813162","phase":"PHASE1","title":"In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products","status":"COMPLETED","sponsor":"CONRAD","startDate":"2013-12","conditions":"HIV Prevention","enrollment":101},{"nctId":"NCT02245945","phase":"PHASE1","title":"Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females","status":"WITHDRAWN","sponsor":"CONRAD","startDate":"","conditions":"HIV Prevention","enrollment":""},{"nctId":"NCT01810315","phase":"PHASE1","title":"Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity","status":"COMPLETED","sponsor":"CONRAD","startDate":"2013-09","conditions":"HIV Prevention","enrollment":40},{"nctId":"NCT01421368","phase":"PHASE1","title":"Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use","status":"COMPLETED","sponsor":"CONRAD","startDate":"2012-03","conditions":"HIV Prevention","enrollment":72},{"nctId":"NCT01369303","phase":"PHASE1","title":"Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel","status":"COMPLETED","sponsor":"CONRAD","startDate":"2012-01","conditions":"Prevention","enrollment":194},{"nctId":"NCT01557179","phase":"PHASE2","title":"Evaluation of the Efficacy and Safety of Hyaluronic Acid Vaginal Gel to Ease Vaginal Dryness","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2009-05","conditions":"The Primary Objective of This Study Was to Assess the Efficacy and Safety of Hyaluronic Acid Vaginal Gel in Treating Vaginal Dryness","enrollment":144},{"nctId":"NCT01122342","phase":"PHASE1, PHASE2","title":"Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.","status":"SUSPENDED","sponsor":"University of Vermont","startDate":"2006-12","conditions":"Vaginitis, Dyspareunia, Breast Neoplasms","enrollment":30}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"HYPERTONIA"}],"_approvalHistory":[],"publicationCount":72,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Testosterone Cream"],"phase":"marketed","status":"active","brandName":"Vaginal Cream with Applicator","genericName":"Vaginal Cream with Applicator","companyName":"Koc University Hospital","companyId":"koc-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A vaginal cream formulation that delivers therapeutic agents topically to treat local vaginal conditions. Used for Vaginal conditions (specific indication not specified).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}